Ascendia Pharmaceuticals
Exhibitors
Information
Ascendia Pharmaceutical Solutions is a specialty US CDMO providing custom formulation development and manufacturing. We deliver sophisticated formulations to enhance bioavailability, solubility and stability, while reducing toxicity using GRAS (Generally Regarded As Safe) materials and 4 proprietary nanotechnologies - NanoSol, EmulSol, AmorSol and LipidSol. Following formulation selection and optimization, Ascendia can scale-up a development program quickly to cGMP manufacturing of clinical materials. Ascendia offers both aseptic and non-aseptic manufacturing for small molecules and biologics.
Exhibitor Type
Exhibitor
Organization Type
Manufacturer/InnovatorCMO/CDMO
Country
United States
Markets Active In
OceaniaNorth America (USA, Canada)AfricaMiddle East Region (e.g. UAE)Central America (e.g. Mexico)East Asia (e.g. China, Japan, Korea)Europe - EU countriesEurope - non EU (e.g. UK, Russia, ex-CIS countries)South America (e.g. Brazil, Colombia)South Asia (e.g. India, Pakistan, Sri Lanka)South East Asia (e.g. Thailand, Philippines, Singapore)
Products and Services
Contract Development and Manufacturing Organisations (CDMOs) and Contract Manufacturing Organisations (CMOs) (Services)
Service Categories
Contract ManufacturingFormulation development
Company Certification
ISOGMP
Service Types
Contract Development and Manufacturing Organisations (CDMOs) and Contract Manufacturing Organisations (CMOs) (Services)
